Judy C. Boughey, MD, on Can De-escalating Axillary Surgery After Chemotherapy for Breast Cancer Improve Outcomes?

Posted: Friday, April 5, 2024

Judy C. Boughey, MD, of the Mayo Clinic, discusses her findings from the I-SPY2 trial which show that, in patients with pN0 and pN+ disease after neoadjuvant chemotherapy, omitting axillary lymph node dissection is not associated with poorer axillary control, locoregional control, or distant relapse–free and event-free survival.

---